| UHC Commercial Medical & Drug | Trogarzo® (Ibalizumab-Uiyk) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Ambulance Services – Community Plan Medical Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Chemotherapy Observation or Inpatient Hospitalization – Community Plan Medical Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Cochlear Implants – Community Plan Medical Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Cosentyx® (Secukinumab) – Community Plan Medical Benefit Drug Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Gynecomastia Surgery (for Florida Only) – Community Plan Medical Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Gynecomastia Surgery – Community Plan Medical Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Habilitation and Rehabilitation Therapy (Occupational, Physical, and Speech) – Site of Service (for Florida Only) – Community Plan Medical Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Hearing Aids and Devices Including Wearable, Bone-Anchored, and Semi-Implantable – Community Plan Medical Policy | 2026-06-01 |
| UHC Medicaid Medical & Drug | Hemgenix® (Etranacogene Dezaparvovec-Drlb) – Community Plan Medical Benefit Drug Policy | 2026-06-01 |